Shameze Rampertab - Jul 1, 2023 Form 4 Insider Report for ASENSUS SURGICAL, INC. (ASXC)

Role
EVP, Chief Financial Officer
Signature
/s/ Joshua Weingard, as attorney-in-fact for Shameze Rampertab
Stock symbol
ASXC
Transactions as of
Jul 1, 2023
Transactions value $
-$3,557
Form type
4
Date filed
7/5/2023, 05:30 PM
Previous filing
Apr 25, 2023
Next filing
Feb 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASXC Common Stock Options Exercise $0 +16.7K +7% $0.00 255K Jul 1, 2023 Direct F1
transaction ASXC Common Stock Tax liability -$3.56K -6.98K -2.74% $0.51 248K Jul 1, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASXC Restricted Stock Units Options Exercise $0 -10K -100% $0.00* 0 Jul 1, 2023 Common Stock 10K $0.00 Direct F2, F3
transaction ASXC Restricted Stock Units Options Exercise $0 -6.67K -100% $0.00* 0 Jul 1, 2023 Common Stock 6.67K $0.00 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Lapse of forfeiture restrictions on one third of the grant of the time-based restricted stock units ("RSUs") and on one third of the performance-based RSUs awarded on August 24, 2020.
F2 Each RSU represents the right to receive one share of the Registrant's common stock.
F3 Lapse of forfeiture restrictions on the 10,000 time-based RSUs from this grant made on August 24, 2020.
F4 Lapse of forfeiture restrictions on the 6,666 performance-based RSUs from this grant made on August 24, 2020.